Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06294691 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 1 month later Nov 30, 2025 → Dec 31, 2027
See other at-risk trials from Anhui Provincial Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Nov 30, 2025 to Dec 31, 2027
    • Study completion pushed from Aug 31, 2026 to Dec 31, 2028
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary endpoint revised
    • Study sites: 1 to 6
    • Start date changed from estimate of Mar 1, 2024 to Mar 15, 2024
    • Secondary endpoints revised (9)
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To observe the effect of stem cell infusion on the development of acute graft- versus-host disease (aGVHD) in patients with nonmalignant hematologic diseases after allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT)
Trial Details
NCT Number NCT06294691
Lead Sponsor Anhui Provincial Hospital
Conditions
(from sponsor)		 Acute Graft-versus-host Disease
Enrollment 198 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov